Optimal positive lymph node ratio showing the benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: an exploratory study using the Surveillance, Epidemiology, and End Results data
Radiation Oncology Journal. 2022;40(1):37-44 
Postoperative Radiotherapy for Stage II or III Non–Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database
Yearbook of Oncology. 2007;2007:183-184
A Nomogram with Lymph Node Status Predicts Survival and the Benefit of Postoperative Radiotherapy in IIIA-N2 Non-small Cell Lung Cancer Patients after Surgery
. 2020;
Postoperative radiotherapy and N2 non-small cell lung cancer prognosis: a retrospective study based on Surveillance, Epidemiology, and End Results database
Journal of Oncology Research. 2021;3(2):
Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology. 2013;8(7):940-946
Stage IIIA pathologic N2 non-small cell lung cancer patients may maximize benefit from preoperative radiotherapy: a population-based study
. 2020;
Use of Postoperative Radiotherapy for Node-Positive non—small-Cell Lung Cancer
Clinical Lung Cancer. 2002;4(1):35-44
Time Trend of Mediastinal Lymph Node Dissection in Stage IA Non-Small Cell Lung Cancer Patient Who Undergo Lobectomy: a Retrospective Study of Surveillance, Epidemiology, and End Results (SEER) database
. 2020;
Postoperative Radiation Therapy for Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer: A Population Study from 1988 to 2014 Using the Surveillance, Epidemiology, and End Results Database
International Journal of Radiation Oncology*Biology*Physics. 2018;102(3):e720
Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non–Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results Database
Journal of Thoracic Oncology. 2012;7(12):1798-1806